A citation-based method for searching scientific literature

Philipp Harter, Jalid Sehouli, Domenica Lorusso, Alexander Reuss, Ignace Vergote, Christian Marth, Jae-Weon Kim, Francesco Raspagliesi, Björn Lampe, Giovanni Aletti, Werner Meier, David Cibula, Alexander Mustea, Sven Mahner, Ingo B Runnebaum, Barbara Schmalfeldt, Alexander Burges, Rainer Kimmig, Giovanni Scambia, Stefano Greggi, Felix Hilpert, Annette Hasenburg, Peter Hillemanns, Giorgio Giorda, Ingo von Leffern, Carmen Schade-Brittinger, Uwe Wagner, Andreas du Bois. N Engl J Med 2019
Times Cited: 148







List of co-cited articles
610 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer.
Ignace Vergote, Claes G Tropé, Frédéric Amant, Gunnar B Kristensen, Tom Ehlen, Nick Johnson, René H M Verheijen, Maria E L van der Burg, Angel J Lacave, Pierluigi Benedetti Panici,[...]. N Engl J Med 2010
25

Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial.
Pierluigi Benedetti Panici, Angelo Maggioni, Neville Hacker, Fabio Landoni, Sven Ackermann, Elio Campagnutta, Karl Tamussino, Raimund Winter, Antonio Pellegrino, Stefano Greggi,[...]. J Natl Cancer Inst 2005
281
20

Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial.
Sean Kehoe, Jane Hook, Matthew Nankivell, Gordon C Jayson, Henry Kitchener, Tito Lopes, David Luesley, Timothy Perren, Selina Bannoo, Monica Mascarenhas,[...]. Lancet 2015
570
19


Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.
Kathleen Moore, Nicoletta Colombo, Giovanni Scambia, Byoung-Gie Kim, Ana Oaknin, Michael Friedlander, Alla Lisyanskaya, Anne Floquet, Alexandra Leary, Gabe S Sonke,[...]. N Engl J Med 2018
775
15

Potential role of lymphadenectomy in advanced ovarian cancer: a combined exploratory analysis of three prospectively randomized phase III multicenter trials.
Andreas du Bois, Alexander Reuss, Philipp Harter, Eric Pujade-Lauraine, Isabelle Ray-Coquard, Jacobus Pfisterer. J Clin Oncol 2010
95
14

Randomised study of systematic lymphadenectomy in patients with epithelial ovarian cancer macroscopically confined to the pelvis.
A Maggioni, P Benedetti Panici, T Dell'Anna, F Landoni, A Lissoni, A Pellegrino, R S Rossi, S Chiari, E Campagnutta, S Greggi,[...]. Br J Cancer 2006
165
14


Pattern and clinical predictors of lymph node metastases in epithelial ovarian cancer.
P Harter, K Gnauert, R Hils, T G Lehmann, A Fisseler-Eckhoff, A Traut, A du Bois. Int J Gynecol Cancer 2007
85
15

Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer.
Willemien J van Driel, Simone N Koole, Karolina Sikorska, Jules H Schagen van Leeuwen, Henk W R Schreuder, Ralph H M Hermans, Ignace H J T de Hingh, Jacobus van der Velden, Henriëtte J Arts, Leon F A G Massuger,[...]. N Engl J Med 2018
486
11

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
11

The potential therapeutic role of lymph node resection in epithelial ovarian cancer: a study of 13918 patients.
J K Chan, R Urban, J M Hu, J Y Shin, A Husain, N N Teng, J S Berek, K Osann, D S Kapp. Br J Cancer 2007
85
11

Ovarian cancer statistics, 2018.
Lindsey A Torre, Britton Trabert, Carol E DeSantis, Kimberly D Miller, Goli Samimi, Carolyn D Runowicz, Mia M Gaudet, Ahmedin Jemal, Rebecca L Siegel. CA Cancer J Clin 2018
957
10

Incorporation of bevacizumab in the primary treatment of ovarian cancer.
Robert A Burger, Mark F Brady, Michael A Bookman, Gini F Fleming, Bradley J Monk, Helen Huang, Robert S Mannel, Howard D Homesley, Jeffrey Fowler, Benjamin E Greer,[...]. N Engl J Med 2011
10

Cancer statistics, 2020.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2020
10

What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?
D S Chi, E L Eisenhauer, J Lang, J Huh, L Haddad, N R Abu-Rustum, Y Sonoda, D A Levine, M Hensley, R R Barakat. Gynecol Oncol 2006
405
9

Detection of nodal metastases by 18F-FDG PET/CT in apparent early stage ovarian cancer: a prospective study.
Mauro Signorelli, Luca Guerra, Cecilia Pirovano, Cinzia Crivellaro, Robert Fruscio, Alessandro Buda, Marco Cuzzucrea, Federica Elisei, Lorenzo Ceppi, Cristina Messa. Gynecol Oncol 2013
41
21

Systematic pelvic and aortic lymphadenectomy in advanced ovarian cancer patients at the time of interval debulking surgery: a double-institution case-control study.
Anna Fagotti, Pierandrea De Iaco, Francesco Fanfani, Giuseppe Vizzielli, Federica Perelli, Federica Pozzati, Anna Myriam Perrone, Luigi Carlo Turco, Giovanni Scambia. Ann Surg Oncol 2012
29
31

Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer.
Isabelle Ray-Coquard, Patricia Pautier, Sandro Pignata, David Pérol, Antonio González-Martín, Regina Berger, Keiichi Fujiwara, Ignace Vergote, Nicoletta Colombo, Johanna Mäenpää,[...]. N Engl J Med 2019
304
9

Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial.
Eric Pujade-Lauraine, Jonathan A Ledermann, Frédéric Selle, Val Gebski, Richard T Penson, Amit M Oza, Jacob Korach, Tomasz Huzarski, Andrés Poveda, Sandro Pignata,[...]. Lancet Oncol 2017
705
9

Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.
Antonio González-Martín, Bhavana Pothuri, Ignace Vergote, René DePont Christensen, Whitney Graybill, Mansoor R Mirza, Colleen McCormick, Domenica Lorusso, Paul Hoskins, Gilles Freyer,[...]. N Engl J Med 2019
384
9

Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis.
Robert E Bristow, Rafael S Tomacruz, Deborah K Armstrong, Edward L Trimble, F J Montz. J Clin Oncol 2002
9

Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): Final analysis of peri-operative outcome.
Anna Fagotti, Gabriella Ferrandina, Giuseppe Vizzielli, Francesco Fanfani, Valerio Gallotta, Vito Chiantera, Barbara Costantini, Pasquale Alessandro Margariti, Salvatore Gueli Alletti, Francesco Cosentino,[...]. Eur J Cancer 2016
169
8

Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer.
Robert L Coleman, Gini F Fleming, Mark F Brady, Elizabeth M Swisher, Karina D Steffensen, Michael Friedlander, Aikou Okamoto, Kathleen N Moore, Noa Efrat Ben-Baruch, Theresa L Werner,[...]. N Engl J Med 2019
231
8

A phase 3 trial of bevacizumab in ovarian cancer.
Timothy J Perren, Ann Marie Swart, Jacobus Pfisterer, Jonathan A Ledermann, Eric Pujade-Lauraine, Gunnar Kristensen, Mark S Carey, Philip Beale, Andrés Cervantes, Christian Kurzeder,[...]. N Engl J Med 2011
8

Lymph node involvement in epithelial ovarian cancer: analysis of 276 pelvic and paraaortic lymphadenectomies and surgical implications.
Philippe Morice, Franklin Joulie, Sophie Camatte, David Atallah, Roman Rouzier, Patricia Pautier, Christophe Pomel, Catherine Lhommé, Pierre Duvillard, Damienne Castaigne. J Am Coll Surg 2003
150
7


TRUST: Trial of Radical Upfront Surgical Therapy in advanced ovarian cancer (ENGOT ov33/AGO-OVAR OP7).
Alexander Reuss, Andreas du Bois, Philipp Harter, Christina Fotopoulou, Jalid Sehouli, Giovanni Aletti, Frederic Guyon, Stefano Greggi, Berit Jul Mosgaard, Alexander Reinthaller,[...]. Int J Gynecol Cancer 2019
39
17

Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials.
Ignace Vergote, Corneel Coens, Matthew Nankivell, Gunnar B Kristensen, Mahesh K B Parmar, Tom Ehlen, Gordon C Jayson, Nick Johnson, Ann Marie Swart, René Verheijen,[...]. Lancet Oncol 2018
83
8

Comparison of treatment invasiveness between upfront debulking surgery versus interval debulking surgery following neoadjuvant chemotherapy for stage III/IV ovarian, tubal, and peritoneal cancers in a phase III randomised trial: Japan Clinical Oncology Group Study JCOG0602.
Takashi Onda, Toyomi Satoh, Toshiaki Saito, Takahiro Kasamatsu, Toru Nakanishi, Kenichi Nakamura, Masashi Wakabayashi, Kazuhiro Takehara, Motoaki Saito, Kimio Ushijima,[...]. Eur J Cancer 2016
103
7

Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study.
Robert F Ozols, Brian N Bundy, Benjamin E Greer, Jeffrey M Fowler, Daniel Clarke-Pearson, Robert A Burger, Robert S Mannel, Koen DeGeest, Ellen M Hartenbach, Rebecca Baergen. J Clin Oncol 2003
7

Overall Survival Following Neoadjuvant Chemotherapy vs Primary Cytoreductive Surgery in Women With Epithelial Ovarian Cancer: Analysis of the National Cancer Database.
J Alejandro Rauh-Hain, Alexander Melamed, Alexi Wright, Allison Gockley, Joel T Clemmer, John O Schorge, Marcela G Del Carmen, Nancy L Keating. JAMA Oncol 2017
58
12


Aggressive surgical effort and improved survival in advanced-stage ovarian cancer.
Giovanni D Aletti, Sean C Dowdy, Bobbie S Gostout, Monica B Jones, C Robert Stanhope, Timothy O Wilson, Karl C Podratz, William A Cliby. Obstet Gynecol 2006
302
7

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).
E A Eisenhauer, P Therasse, J Bogaerts, L H Schwartz, D Sargent, R Ford, J Dancey, S Arbuck, S Gwyther, M Mooney,[...]. Eur J Cancer 2009
7

Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer.
Mansoor R Mirza, Bradley J Monk, Jørn Herrstedt, Amit M Oza, Sven Mahner, Andrés Redondo, Michel Fabbro, Jonathan A Ledermann, Domenica Lorusso, Ignace Vergote,[...]. N Engl J Med 2016
7


Diagnosis and staging of primary ovarian cancer: correlation between PET/CT, Doppler US, and CT or MRI.
Eun Ji Nam, Mi Jin Yun, Young Taik Oh, Jae Wook Kim, Jae Hoon Kim, Sunghoon Kim, Yong Wook Jung, Sang Wun Kim, Young Tae Kim. Gynecol Oncol 2010
115
6

Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm.
Dennis S Chi, Eric L Eisenhauer, Oliver Zivanovic, Yukio Sonoda, Nadeem R Abu-Rustum, Douglas A Levine, Matthew W Guile, Robert E Bristow, Carol Aghajanian, Richard R Barakat. Gynecol Oncol 2009
360
6

Relationship among surgical complexity, short-term morbidity, and overall survival in primary surgery for advanced ovarian cancer.
Giovanni D Aletti, Sean C Dowdy, Karl C Podratz, William A Cliby. Am J Obstet Gynecol 2007
170
6


Role of lymphadenectomy in the management of grossly apparent advanced stage epithelial ovarian cancer.
Giovanni D Aletti, Sean Dowdy, Karl C Podratz, William A Cliby. Am J Obstet Gynecol 2006
53
11

Lymph node metastasis in stages I and II ovarian cancer: a review.
M Kleppe, T Wang, T Van Gorp, B F M Slangen, A J Kruse, R F P M Kruitwagen. Gynecol Oncol 2011
77
7

Diagnostic accuracy of integrated FDG-PET/contrast-enhanced CT in staging ovarian cancer: comparison with enhanced CT.
Kazuhiro Kitajima, Koji Murakami, Erena Yamasaki, Yasushi Kaji, Ichio Fukasawa, Noriyuki Inaba, Kazuro Sugimura. Eur J Nucl Med Mol Imaging 2008
101
6

Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline.
Alexi A Wright, Kari Bohlke, Deborah K Armstrong, Michael A Bookman, William A Cliby, Robert L Coleman, Don S Dizon, Joseph J Kash, Larissa A Meyer, Kathleen N Moore,[...]. Gynecol Oncol 2016
125
6

Secondary Surgical Cytoreduction for Recurrent Ovarian Cancer.
Robert L Coleman, Nick M Spirtos, Danielle Enserro, Thomas J Herzog, Paul Sabbatini, Deborah K Armstrong, Jae-Weon Kim, Sang-Yoon Park, Byoung-Gie Kim, Joo-Hyun Nam,[...]. N Engl J Med 2019
83
7

The efficacy of systematic lymph node dissection in advanced epithelial ovarian cancer during interval debulking surgery performed after neoadjuvant chemotherapy.
Kyung Jin Eoh, Jung Won Yoon, Inok Lee, Jung-Yun Lee, Sunghoon Kim, Sang Wun Kim, Young Tae Kim, Eun Ji Nam. J Surg Oncol 2017
8
75

Patterns of Lymph Node Metastases in Apparent Stage I Low-Grade Epithelial Ovarian Cancer: A Multicenter Study.
Lucas Minig, Florian Heitz, David Cibula, Jamie N Bakkum-Gamez, Anna Germanova, Sean C Dowdy, Eleftheria Kalogera, Ignacio Zapardiel, Kristina Lindemann, Philipp Harter,[...]. Ann Surg Oncol 2017
27
22

Randomized Trial of Intravenous Versus Intraperitoneal Chemotherapy Plus Bevacizumab in Advanced Ovarian Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study.
Joan L Walker, Mark F Brady, Lari Wenzel, Gini F Fleming, Helen Q Huang, Paul A DiSilvestro, Keiichi Fujiwara, David S Alberts, Wenxin Zheng, Krishnansu S Tewari,[...]. J Clin Oncol 2019
77
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.